30th Annual Meeting of the European Society for Paediatric Infectious Diseases
HIV Drug Therapy in the Americas
11th Vaccines Research and Development: All Things Considered Conference
31st Annual Conference on Pediatric Infectious Diseases
Find Practice Guidelines
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
More Guidance Needed in DURC Oversight Policy (PDF)
U.S. policy for institutional oversight of dual use research of concern (DURC) should include more specific guidance, IDSA urged.
More Data Needed on Antibiotic Use in Animals (PDF)
IDSA and other groups urged Congress to pass legislation to provide better information on antimicrobial use in food animals.
Oxytetracycline Use in Agriculture Raises Concerns (PDF)
IDSA called for an end to the authorized use of the antibiotic on fruit orchards, pending more research.
IDSA Calls for Strong Funding for Federal Health Agencies (PDF)
Investments in ID research and public health can reduce health care costs, save lives, and create jobs, the Society told House lawmakers.
Stronger Communication Needed to Address Drug Shortages (PDF)
IDSA and PIDS call for better communication between federal agencies, industry, and providers to help prevent drug shortages.
New Antibiotic Approval Pathway Urgently Needed (PDF)
In comments to FDA, IDSA highlighted the need for a new approval pathway for antibiotics needed to treat the most serious infections.
Protect Graduate Medical Education Against Funding Cuts (PDF)
IDSA, HIVMA, and other groups asked Congress to preserve funding for physician training at teaching hospitals in a full-page newspaper ad.
1 of 8
In Cooperation with FDA, The Compounding Shop, LLC Declares a Voluntary Recall of All Lots of Sterile Compounded Products Due to a Lack of Sterility Assurance Distributed Within its Local Market Area
FDA Recall: Piperacillin and Tazobactam for Injection, USP 40.5 grams - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
FDA Announces Voluntary Nationwide Recall by Balanced Solutions Compounding Pharmacy
Resources Available for Local and State Public Health Officials: Preparing for and Responding to Bombing Events
CDC HAN Alert
the full issue
Top Stories:From the President: Your Voice Can Make a DifferenceIDSA Report: Antibiotic Pipeline Progress “Alarmingly Elusive”“Ask the Coder” Your Tough Coding QuestionsIDSA Journal
>> Read more
Despite the need for new antibiotics, only one new systemic antibiotic has been approved since IDSA launched its 10 x ’20 initiative in 2010.
IDSA applauds several ID-related initiatives in the president’s budget proposal for the 2014 fiscal year but also urges stronger funding for other key priorities.
Call for Nominations
IDSA is seeking nominations for several elected leadership positions. The deadline for nominations is April 1, 2013.
Findings in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine.
New guidelines, jointly developed by IDSA and other groups, are intended to guide medication use to prevent surgical site infections and avoid antibiotic resistance.
Increase the accuracy of ID physicians’ compensation data by participating in the influential Medical Group Management Association’s (MGMA) 2013 physician compensation survey.
1 of 7
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America